GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer. Wang Y, Pan J, An F, Chen K, et al. BMC Cancer 2023;23:925.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Pan J, An F, Chen K, et al. GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer. BMC Cancer 2023;23:925.
PMID: 37784054